Systematic Review Onmicron needles Drug Delivery in the Management of Various Disorders
International Journal of Community Pharmacy · 30.06.2025 · 20-24
DOI: 10.65301/ijcp.2025.6.2.3 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Community Pharmacy, online erschienen am 30.06.2025. Verfasst von Seema Mudho und 2 weiteren Autor:innen. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Microneedle transdermal distribution is a method of providing medicinal substances to specific organs or tissues that involves inserting very small needles into the stratum corneum, the skin's outermost layer. Many people feel that this procedure couldeventually replace the more common practice of administering medication to patients by injection. Microneedles (MNs) are a revolutionary form of drug administration that allows for the least invasive entry of medicinal substances into a variety of tissues, including skin. This review delves deeply into the use of microneedles in the diagnosis and treatment of a variety of medical conditions, including cancer, diabetes, obesity, neuropathic pain, neurological disorders, respiratory problems, wounds, acne, ophthalmic illnesses, and wound healing
Zitieren
APA
Mudho, S., N, V. R., & Joshi, H. (2025). Systematic Review Onmicron needles Drug Delivery in the Management of Various Disorders. International Journal of Community Pharmacy, 20-24. https://doi.org/10.65301/ijcp.2025.6.2.3
Vancouver
Mudho S, N VR, Joshi H. Systematic Review Onmicron needles Drug Delivery in the Management of Various Disorders. International Journal of Community Pharmacy. 2025:20-24. doi:10.65301/ijcp.2025.6.2.3
BibTeX
@article{Mudho2025,
author = {Mudho, Seema and N, Venkat Rao and Joshi, Hanumanthachar},
title = {Systematic Review Onmicron needles Drug Delivery in the Management of Various Disorders},
journal = {International Journal of Community Pharmacy},
year = {2025},
pages = {20--24},
doi = {10.65301/ijcp.2025.6.2.3}
}
EUVIMED